Sandu Pharmaceuticals Ltd. (BSE: 524703) is a Mumbai, Maharashtra-based company in the Vitamins and Nutritional Supplements industry. With a market capitalisation of ₹34 Cr, it ranks #4,162 by market cap among the 6,137 Indian listed companies on FinBizNet, and #3 of 5 in Vitamins and Nutritional Supplements. At ₹33.99 (as of 25 Oct 2026), the share price is 32.0% below its 52-week high of ₹50.00 and 13.3% above its 52-week low of ₹30.00. The share price is down 22.9% over one year and down 13.5% over three months.
| Current Price | ₹33.99 |
|---|---|
| Market Cap | ₹34 Cr |
| BSE Code | 524703 |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Vitamins and Nutritional Supplements |
| P/E Ratio | 19.6 |
| Return on Equity | 4.13% |
| Return on Assets | 2.60% |
| 52-Week Range | ₹30.00 – ₹50.00 |
| 1-Year Price Change | -22.9% |
| 3-Month Price Change | -13.5% |
| Beta (1Y) | 0.53 |
| Dividend Yield | 2.79% |
| Headquarters | Mumbai, Maharashtra |
| Website | sandu.in |
| Revenue | ₹16 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 1.4% |
| EPS (Basic) | ₹0.37 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasava, stressan, ashwagandharishtam, sandu sitopalasava, makarprash, chyavanprash, and ayush kwath. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.
1. Ayurvedic Property Medicines-This segment engages in the manufacture and marketing of ayurvedic medicines.
1. Ayurvedic Property Medicines-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Hexagon Nutrition Limited | ₹899 Cr | 22.2 | 16.26% | ₹104 Cr | — |
| Aayush Food And Herbs Ltd | ₹123 Cr | 31.1 | 38.75% | — | -67.8% |
| Sandu Pharmaceuticals Ltd. | ₹34 Cr | 19.6 | 4.13% | ₹16 Cr | -22.9% |
| Deccan Health Care Ltd | ₹30 Cr | 12.8 | 2.11% | ₹22 Cr | -19.8% |
| Walpar Nutritions Limited | ₹25 Cr | 9.9 | 15.68% | — | -40.1% |
Listed by market capitalisation. Ratios are shown for context only.
Sandu Pharmaceuticals Ltd. is trading at ₹33.99, with a market capitalisation of ₹34 Cr.
Sandu Pharmaceuticals Ltd. operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).
Sandu Pharmaceuticals Ltd. has a P/E of 19.6 and a return on equity of 4.13%.
Sandu Pharmaceuticals Ltd. is listed on the BSE under the scrip code 524703.
Sandu Pharmaceuticals Ltd.'s share price is down 22.9% over one year and down 13.5% over three months. Its 52-week range is ₹30.00 to ₹50.00.
In Q1 FY27, Sandu Pharmaceuticals Ltd. reported revenue of ₹16 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.37 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.